Skip to content

Flexion Therapeutics, Inc.: 10-K filed 2015-03-24

What Flexion Therapeutics, Inc. reported in its annual report filed 2015-03-24 (fiscal FY 2014): 32 published measures, 93 facts as tagged in accession 0001193125-15-103253.

This filing

Form
10-K (annual report)
Filed
2015-03-24
Fiscal period
fiscal FY 2014
Accession
0001193125-15-103253 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All Flexion Therapeutics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-12-31153,376,758USD
At 2013-12-3118,775,917USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-12-318,434,867USD
At 2013-12-318,673,594USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-12-31144,941,891USD
At 2013-12-31-64,703,890USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-12-31103,097,522USD
At 2013-12-3116,188,254USD
At 2012-12-3112,835,330USD
At 2011-12-313,357,482USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-10-01 to 2014-12-31-7,805,211USD92
2014-01-01 to 2014-12-31-27,313,664USD365
2014-07-01 to 2014-09-30-7,035,607USD92
2014-04-01 to 2014-06-30-5,930,602USD91
2014-01-01 to 2014-03-31-6,542,244USD90
2013-10-01 to 2013-12-31-3,690,485USD92
2013-01-01 to 2013-12-31-18,186,724USD365
2013-07-01 to 2013-09-30-5,100,378USD92
2013-04-01 to 2013-06-30-4,597,774USD91
2013-01-01 to 2013-03-31-4,798,087USD90
2012-01-01 to 2012-12-31-14,981,619USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-12-31802,481USD365
2013-01-01 to 2013-12-31405,315USD365
2012-01-01 to 2012-12-3134,914USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-12-31-93,476,823USD
At 2013-12-31-66,163,159USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-01-01 to 2014-12-310USD365
2013-01-01 to 2013-12-310USD365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-12-311,109,391USD
At 2013-12-31375,239USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-26,987,274USD365
2013-01-01 to 2013-12-31-17,765,209USD365
2012-01-01 to 2012-12-31-15,011,642USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-12-31152,126,992USD
At 2013-12-3116,620,263USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-01-01 to 2014-12-31401,370USD365
2013-01-01 to 2013-12-31448,889USD365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-12-316,798,526USD
At 2013-12-315,036,554USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-12-311,584,822USD
At 2013-12-311,279,874USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-10-01 to 2014-12-317,741,370USD92
2014-01-01 to 2014-12-3126,987,274USD365
2014-07-01 to 2014-09-306,962,319USD92
2014-04-01 to 2014-06-305,848,825USD91
2014-01-01 to 2014-03-316,434,760USD90
2013-10-01 to 2013-12-313,577,296USD92
2013-01-01 to 2013-12-3117,765,209USD365
2013-07-01 to 2013-09-304,990,196USD92
2013-04-01 to 2013-06-304,490,078USD91
2013-01-01 to 2013-03-314,707,639USD90
2012-01-01 to 2012-12-3115,011,642USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-01-01 to 2014-12-3117,923,348USD365
2013-01-01 to 2013-12-3111,060,912USD365
2012-01-01 to 2012-12-3111,065,137USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-12-3121,440,058shares
At 2013-12-31794,090shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-12-31-5,240USD
At 2013-12-31-28USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-12-311,377,830USD
At 2013-12-31636,839USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-12-31268,439USD
At 2013-12-31261,600USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-12-3112,375USD
At 2013-12-3128,875USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-12-3143,008USD
At 2013-12-3190,373USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-12-313,213,704USD
At 2013-12-312,256,680USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2014-12-31502,314USD
At 2013-12-31181,962USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2014-12-310USD
At 2013-12-310USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-27,318,876USD365
2013-01-01 to 2013-12-31-18,189,202USD365
2012-01-01 to 2012-12-31-14,979,972USD366

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-27,313,664USD365
2013-01-01 to 2013-12-31-18,186,724USD365
2012-01-01 to 2012-12-31-14,981,619USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-12-319,063,926USD365
2013-01-01 to 2013-12-316,704,297USD365
2012-01-01 to 2012-12-313,946,505USD366

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-01-01 to 2014-12-31120,341USD365
2013-01-01 to 2013-12-3179,808USD365
2012-01-01 to 2012-12-3143,233USD366

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-403,735USD365
2013-01-01 to 2013-12-31-206,625USD365
2012-01-01 to 2012-12-31-163,877USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-326,390USD365
2013-01-01 to 2013-12-31-421,515USD365
2012-01-01 to 2012-12-3130,023USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-01-01 to 2014-12-31162,137,580USD365
2008-12-01 to 2008-12-3120,750USD31

Inspect the source

Entity
Flexion Therapeutics, Inc. / CIK 0001419600
Captured
SEC response SHA-256
cae626814ebee92ae39e27e46ff05270689f0133332b9b03eb0069a1ad1470ea

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001419600.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))